Works Cited

1. Cobb CM. Microbes, inflammation, scaling and root planning, and the periodontal condition.J Dent Hyg. 2008;82(Suppl 3):4-9.

2. Merck Manuals Online. Periodontitis. Available at Last accessed January 26, 2023.

3. Paquette DW, Ryan ME, Wilder RS. Locally delivered antimicrobials: clinical evidence and relevance.J Dent Hyg. 2008;82(Suppl 3): 10-15.

4. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions.Periodontology. 1997;14:216-248.

5. U.S. Department of Health and Human Services.A Report of the Task Force on the NIH Women's Health Research Agenda for the 21st Century, Volume 1. Executive Summary. Bethesda, MD: National Institutes of Health; 1999.

6. 6. National Institute of Dental and Craniofacial Research. 2000 Surgeon General's Report on Oral Health in America. Available at Last accessed January 26, 2023.

7. Suri V, Suri V. Menopause and oral health.J Midlife Health. 2014;5(3):115-120.

8. Soikkonen K, Wolf J, Salo T, Tilvis R. Radiographic periodontal attachment loss as an indicator of death risk in the elderly.J Clin Periodontol. 2000;27(2):87-92.

9. Dhadse P, Gattani D, Mishra R. The link between periodontal disease and cardiovascular disease: how far we have come in last two decades?J Indian Soc Periodontol. 2010;14(3):148-154.

10. Teng YT, Taylor GW, Scannapieco F, et al. Periodontal health and systemic disorders.J Can Dent Assoc. 2002;68(3):188-192.

11. Arigbede AO, Babatope BO, Bamidele MK. Periodontitis and systemic diseases: a literature review.J Indian Soc Periodontol. 2012;16(4):487-491.

12. Anil S, Al-Ghamdi HS. The impact of periodontal infections on systemic disease: an update for medical practitioners.Saudi Med J. 2006;27(6):767-776.

13. Ford PJ, Raphael SL, Cullinan MP, Jenkins AJ, West MJ, Seymour GJ. Why should a doctor be interested in oral disease?Expert Rev Cardiovasc Ther. 2010;8(10):1483-1493.

14. Demmer RT, Desvarieux M. Periodontal infections and cardiovascular disease: the heart of the matter.J Am Dent Assoc. 2006;137(Suppl):14S-20S.

15. Anderson SE, Must A. Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart.J Pediatr. 2005;147(6):753-760.

16. Weinberg MA. Women and Oral Health. Available at Last accessed January 26, 2023.

17. 17. HealthPartners Dental Group and Clinics.Guidelines for the Diagnosis and Treatment of Periodontal Diseases. Minneapolis, MN: HealthPartners; 2006.

18. American Dental Association Council on Access, Prevention, and Interprofessional Relations. Women's oral health issues. In:ADA Oral Health Care Series. Chicago, IL: American Dental Association; 1995: 9.

19. Dong A. Dysmenorrhea. Available at Last accessed January 26, 2023.

20. Moreno MA. Premenstrual Syndrome. Available at Last accessed January 26, 2023.

21. Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines, 2021. Available at Last accessed January 26, 2023.

22. Mashburn J. Etiology, diagnosis, and management of vaginitis.J Midwifery Womens Health. 2006;51(6):423-430.

23. Youngkin EQ, Davis MS, Schadewald D, Juve C.Women's Health: A Primary Care Clinical Guide. 4th ed. New York, NY: Pearson; 2012.

24. Chan PD, Johnson SM.Gynecology and Obstetrics. 9th ed. Laguna Hills, CA: Current Clinical Strategies; 2007.

25. Taber's Online. Available at Last accessed January 26, 2023.

26. Cottrell BH. Vaginal douching.J Obstet Gynecol Neonatal Nurs. 2003;32(1):12-18.

27. Mayo Clinic. Endometriosis. Available at Last accessed January 26, 2023.

28. Guo SW, Wang Y. The prevalence of endometriosis in women with chronic pelvic pain.Gynecol Obstet Invest. 2006;62:121-130.

29. Borgelt-Hansen L. Oral contraceptives: an update on health benefits and risks.J Am Pharm Assoc. 2001;41(6).

30. Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: a meta-analysis.JAMA. 2000;281(1):72-78.

31. Tanis BC. Oral contraceptives and the risk of myocardial infarction.Eur Heart J. 2003;24(5):377-380.

32. Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Stroke. 2014;45(12):3754-3832.

33. Kennon S, Tasch EG, Arm RN. Considerations in the management of patients taking oral contraceptives.J Am Dent Assoc. 1978;97(4):641-643.

34. Jensen J, Liljemark W, Bloomquist C. The effect of female sex hormones on subgingival plaque.J Periodontol. 1981;52(10):599-602.

35. Magnusson T, Ericson T, Hugoson A. The effect of oral contraceptives on the concentration of some salivary substances in women.Arch Oral Biol. 1975;20(2):119-126.

36. El-Ashiry GM, El-Kafrawy AH, Nasr MF, Younis N. Effects of oral contraceptives on the gingiva.J Periodontol. 1971;42(5):273-275.

37. Almeida LE, Pierce S, Klar K, Sherman K. Effects of oral contraceptives on the prevalence of alveolar osteitis after mandibular third molar surgery: a retrospective study.Int J Oral Maxillofac Surg. 2016;45(10):1299-1302.

38. Rose LF, Kaye D (eds).Internal Medicine for Dentistry. 2nd ed. St. Louis, MO: Mosby; 1990.

39. Sweet JB, Butler DP. Increased incidence of postoperative localized osteitis in mandibular third molar surgery associated with patients using oral contraceptives.Am J Obstet Gynecol. 1977;127(5):518-519.

40. Castellini J, Harvey D, Erickson S, Cherkin D. Effect of oral contraceptive cycle on dry socket (localized alveolar osteitis).J Am Dent Assoc. 1980;101(5):777-780.

41. Tolstunov L. Influence of immediate post-extraction socket irrigation on development of alveolar osteitis after mandibular third molar removal: a prospective split-mouth study, preliminary report.Br Dent J. 2012;213(12):597-601.

42. Bailey E, Kashbour W, Shas N, Worthington HV, Renton TF, Coulthard P. Surgical techniques for the removal of mandibular wisdom teeth.Cochrane Database Syst Rev. 2020;(7):CD004345.

43. Brusca MI, Rosa A, Albaina O, Moragues MD, Verdugo F, Ponton J. The impact of oral contraceptives on women's periodontal health and the subgingival occurrence of aggressive periodontopathogens and Candida species.J Periodontol. 2010;81(7):1010-1018.

44. ADA Council on Scientific Affairs. Antibiotic interference with oral contraceptives.J Am Dent Assoc. 2002;133(7):880.

45. Burroughs KE, Chambliss ML. Antibiotics and oral contraceptive failure.Arch Fam Med. 2000;9:81-82.

46. Hatcher RA, Trussell J, Nelson AL, Cates W, Kowal D, Policar M.Contraceptive Technology. 20th ed. New York, NY: Ardent Media; 2011.

47. Kornman KS, Loesche WJ. The subgingival microbial flora during pregnancy.J Periodont Res. 1980;15(2):111-122.

48. Carrillo-de-Albornoz A, Figuero E, Herrera D, Bascones-Martinez A. Gingival changes during pregnancy: II. Influence of hormonal variations on the subgingival biofilm.J Clin Periodontol. 2010;37(3):230-240.

49. Markou E, Eleana B, Lazaros T, Antonios K. The influence of sex steroid hormones on gingiva of women.Open Dent J. 2009;3:114-119.

50. Lindhe J, Branemark PI. Changes in vascular permeability after local application of sex hormones.J Periodontol Res. 1967;2(4):259-265.

51. Mariotti A. Sex steroid hormones and cell dynamics in the periodontium.Crit Rev Oral Biol Med. 1994;5(1):27-53.

52. Soory M. Targets for steroid hormone mediated actions of periodontal pathogens, cytokines and therapeutic agents: some implications on tissue turnover in the periodontium.Curr Drug Targets. 2000;1(4):309-325.

53. Miller LS, Manwell MA, Newbold D, et al. The relationship between reduction in periodontal inflammation and diabetes control: a report of nine cases.J Periodontol. 1992;63(10):843-848.

54. Shlossman M, Knowler WC, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease.J Am Dent Assoc. 1990;121(4):532-536.

55. Nagata T. Relationship between diabetes and periodontal disease.Clin Calcium. 2009;19(9):1291-1298.

56. Liccardo D, Cannavo A, Spagnuolo G, et al. Periodontal disease: a risk factor for diabetes and cardiovascular disease.Int J Mol Sci. 2019;20(6):1414.

57. Genco RJ, Graziani F, Hasturk H. Effects of periodontal disease on glycemic control, complications, and incidence of diabetes mellitus.Periodontol 2000. 2020;83(1):59-65.

58. Stanko P, Holla LI. Bidirectional association between diabetes mellitus and inflammatory periodontal disease. A review.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(1):35-38.

59. Sinha S, Sonoo PR, Siddhartha R, Singh SK, Singh A. Effect of conventional periodontal treatment (scaling and root planing) on type 2 diabetic patients with moderate generalized chronic periodontitis: a clinical study.J Pharm Bioallied Sci. 2021;13(Suppl 1):S706-S710.

60. Santos VR, Lima JA, De Mendonca AC, Braz Maximo MB, Faveri M, Duarte PM. Effectiveness of full-mouth and partial-mouth scaling and root planing in treating chronic periodontitis in subjects with type 2 diabetes.J Periodontol. 2009;80(8):1237-1245.

61. Jeffcoat MK, Geurs NC, Reddy MS, Cliver SP, Goldenberg RL, Hauth JC. Periodontal infection and preterm birth: results of a prospective study.J Am Dent Assoc. 2001;132(7):875-880.

62. Offenbacher S, Katz V, Fertik G, et al. Periodontal infection as a possible risk factor for preterm low birth weight.J Periodontol. 1996;67(10 Suppl):1103-1113.

63. Jeffcoat MK, Geurs NC, Reddy MS, Goldenberg RL, Hauth JC. Current evidence regarding periodontal disease as a risk factor in preterm birth.Ann Periodontol. 2001;6(1):183-188.

64. Turton M, Africa CW. Further evidence for periodontal disease as a risk indicator for adverse pregnancy outcomes.Int Dent J. 2017;67(3):148-156.

65. López NJ, DaSilva I, Ipinza J, Gutiérrez J. Periodontal therapy reduces the rate of preterm low birth weight in women with pregnancy-associated gingivitis.J Periodontol. 2005;76(11):2144-2153.

66. Iheozor-Ejiofor Z, Middleton P, Esposito M, Glenny AM. Treating periodontal disease for preventing adverse birth outcomes in pregnant women.Cochrane Database Syst Rev. 2017;(6):CD005297.

67. Gallagher-Cobos G, Almerich-Torres T, Montiel-Company JM, et al. Relationship between periodontal condition of the pregnant woman with preterm birth and low birth weight.J Clin Med. 2022;11(22):6857.

68. American Academy of Periodontology. Gum Disease and Women. Available at Last accessed January 26, 2023.

69. Carta G, Persia G, Falciglia K, Iovenitti P. Periodontal disease and poor obstetrical outcome.Clin Exp Obstet Gynecol. 2004;31(1):47-49.

70. 70. Horton AL, Boggess KA, Moss KL, Jared HL, Beck J, Offenbacher S. Periodontal disease early in pregnancy is associated with maternal systemic inflammation among African American women.J Periodontol. 2008;79(7):1127-1132.

71. Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. Plasma C-reactive protein in early pregnancy and preterm delivery.Am J Epidemiol. 2005;162(11):1108-1113.

72. Ferguson KK, McElrath TF, Chen YH, Mukherjee B, Meeker JD. Longitudinal profiling of inflammatory cytokines and C-reactive protein during uncomplicated and preterm pregnancy.Am J Reprod Immunol. 2014;72(3):326-336.

73. Offenbacher S, Jared HL, O'Reilly PG, et al. Potential pathogenic mechanisms of periodontitis associated pregnancy complications.Ann Periodontol. 1998;3(1):233-250.

74. Mitchell-Lewis D, Engebretson SP, Chen J, Lamster IB, Papapanou PN. Periodontal infections and pre-term birth: early findings from a cohort of young minority women in New York.Eur J Oral Sci.2001;109(1):34-39.

75. 75. Elias D, Gimenez L, Poletta F, et al. Preterm birth and genitourinary tract infections: assessing gene-environment interaction.Pediatr Res. 2021;90(3):678-683.

76. March of Dimes Peristats. Preterm Birth. Available at Last accessed January 26, 2023.

77. ACOG Committee on Practice Bulletins Obstetrics. ACOG practice bulletin no. 171: management of preterm labor.Obstet Gynecol. 2016;128(4):e155-e164.

78. Thakur RK, Yadav BK, Sultana R, Afridi SK, Das D, Sahoo SK. Influence of periodontal infection as a possible risk factor for preterm low birth weight.J Pharm Bioallied Sci. 2020;12(Suppl 1):S613-S618.

79. Dasanayake AP. Poor periodontal health of the pregnant woman as a risk factor for low birth weight.Ann Periodontol. 1998;3(1):206-212.

80. Rana A, Manjunath S, Bhattacharya H, Influence of maternal periodontitis on adverse pregnancy outcome: an observational study.Dent Res J (Isfahan). 2022;19:21.

81. Khader Y, Al-shishani L, Obeidat B, et al. Maternal periodontal status and preterm low birth weight delivery: a case-control study.Arch Gynecol Obstet. 2009;279(2):165-169.

82. MedlinePlus. Hyperemesis Gravidarum. Available at Last accessed January 26, 2023.

83. Silk H, Douglass AB, Douglass JM, Silk L. Oral health during pregnancy.Am Fam Physician. 2008;77(8):1139-1144.

84. National Cancer Institute. Lifetime Risk of Cancer. Available at Last accessed January 26, 2023.

85. Allen KM, Phillips JM.Women's Health Across the Lifespan: A Comprehensive Perspective. Philadelphia, PA: Lippincott, Williams and Wilkins; 1997.

86. Berman NR. Human papillomavirus and cervical cancer screening: recent advances improve the clinical picture.Adv Nurse Pract. 2002;10(10):26-35.

87. National Cancer Institute. Cervical Cancer. Available at Last accessed January 26, 2023.

88. American Cancer Society. Treating Cervical Cancer. Available at Last accessed January 26, 2023.

89. McClung NM, Gargano JW, Bennett NM, et al. Trends in human papillomavirus vaccine types 16 and 18 in cervical precancers, 2008-2014.Cancer Epidemiol Biomarkers Prev. 2019;28:602-609.

90. McClung NM, Lewis RM, Gargano JW, Querec T, Unger ER, Markowitz LE. Declines in vaccine-type human papillomavirus prevalence in females across racial/ethnic groups: data from a national survey.J Adolesc Health. 2019;65:715-722.

91. McClung NM, Gargano JW, Park IU, et al. Estimated number of cases of high-grade cervical lesions diagnosed among women—United States, 2008 and 2016.MMWR Morb Mortal Wkly Rep. 2019;68:337-343.

92. Fontham ETH, Wolf A, Church TR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.CA Cancer J Clin. 2020;70(5):321-346.

93. U.S. Preventive Services Task Force. Cervical Cancer: Screening. Available at Last accessed January 26, 2023.

94. The American College of Obstetricians and Gynecologists. Updated Cervical Cancer Screening Guidelines: Practice Advisory April 2021. Available at Last accessed January 26, 2023.

95. ACOG. Updated Guidelines for Management of Cervical Cancer Screening Abnormalities. Available at Last accessed January 26, 2023.

96. U.S. Food and Drug Administration. Gardasil Vaccine Safety. Available at Last accessed January 26, 2023.

97. U.S. Food and Drug Administration. Gardasil: Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant. Available at Last accessed January 26, 2023.

98. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).MMWR. 2010;59(20):626-629.

99. Einstein MH, Baron M, Levin MJ, et al. Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years.Hum Vaccin. 2009;5(10):705-719.

100. 100. U.S. Food and Drug Administration. FDA Approves Gardasil 9 for Prevention of Certain Cancers Caused by Five Additional Types of HPV. Available at Last accessed January 26, 2023.

101. U.S. Food and Drug Administration. FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 through 45 Years Old. Available at Last accessed January 26, 2023.

102. Centers for Disease Control and Prevention. Prevent Cervical Cancer. Available at Last accessed January 26, 2023.

103. Centers for Disease Control and Prevention. HPV Vaccine Information for Young Women: Fact Sheet. Available at Last accessed January 26, 2023.

104. American Cancer Society. About Endometrial Cancer. Available at Last accessed January 26, 2023.

105. Banno K, Susumu N, Yanokura M, et al. Association of HNPCC and endometrial cancers.Int J Clin Oncol. 2004;9(4):262-269.

106. Hackley BK, Kriebs JM.Primary Care of Women. 2nd ed. Burlington, MA: Jones & Bartlett Learning; 2017.

107. American Cancer Society. Ovarian Cancer. Available at Last accessed January 26, 2023.

108. 108. American Cancer Society. Chemotherapy for Ovarian Cancer. Available at Last accessed January 26, 2023.

109. Boyd LR, Muggia FM. Carboplatin/paclitaxel induction in ovarian cancer: the finer points.Oncology. 2018;32(8):418-424.

110. National Cancer Institute. Breast Cancer Risk in American Women. Available at Last accessed January 26, 2023.

111. American Cancer Society. Survival Rates for Breast Cancer. Available at Last accessed January 26, 2023.

112. American Cancer Society. Breast Cancer. Available at Last accessed January 26, 2023.

113. National Cancer Institute. Breast Cancer Screening: Overview. Available at Last accessed January 26, 2023.

114. American Cancer Society. American Cancer Society Recommendations for the Early Detection of Breast Cancer. Available at Last accessed January 26, 2023.

115. American College of Obstetricians-Gynecologists. Practice bulletin no. 179: breast cancer risk assessment and screening in average-risk women.Obstet Gynecol. 2017;130(1):e1-e16.

116. 116. National Cancer Institute. Cancer Stat Facts: Female Breast Cancer. Available at Last accessed January 26, 2023.

117. National Cancer Institute. Breast Cancer Treatment: Stage Information for Breast Cancer. Available at Last accessed January 26, 2023.

118. Yackzan SG, Hatch J. Surgical management and reconstruction. In: Mahon SM (ed).Breast Cancer. 2nd ed. Pittsburg, PA: Oncology Nursing Society; 2011: 79-92.

119. Taghian A, El-Ghamry MN, Merajver SD. Inflammatory Breast Cancer: Clinical Features and Treatment. Available at Last accessed January 26, 2023.

120. National Cancer Institute. Oral Complications of Chemotherapy and Head/Neck Radiation. Available at Last accessed January 26, 2023.

121. Zachariasen RD. Oral manifestations of menopause.Compendium. 1993;14(12):1584-1591.

122. Mayo Clinic. Menopause. Available at Last accessed January 26, 2023.

123. George SA. The menopause experience: a woman's perspective.J Obstet Gynecol Neonatal Nurs. 2006;31(1):77-85.

124. Ferguson MM, Carter J, Boyle P, Hart DM, Lindsay R. Oral complaints related to climacteric symptoms in oophorectomized women.J R SocMed. 1981;74(7):492-498.

125. Friedlander AH. The physiology, medical management and oral implications of menopause.J Am Dent Assoc. 2002;133(1):73-81.

126. Frutos R, Rodriguez S, Miralles-Jorda L. Machuca G. Oral manifestations and dental treatment in menopause.Med Oral. 2002;7(1): 26-30, 31-35.

127. Meurman JH, Tarkkila L, Tiitinen A. The menopause and oral health.Maturitas. 2009;63(1):56-62.

128. American Academy of Periodontology.Women and Gum Disease: Your Unique Oral Health Needs. Chicago, IL: American Academy of Periodontology; 1993.

129. International Osteoporosis Foundation. MHT and SERM. Available at Last accessed January 26, 2023.

130. American Heart Association. Suggested Servings from Each Food Group. Available at Last accessed January 26, 2023.

131. American Heart Association. American Heart Association Recommendations for Physical Activity in Adults. Available at Last accessed January 26, 2023.

132. Frackiewicz EJ, Cutler NR. Women's health care during the perimenopause.J Am Pharm Assoc. 2000;40(6).

133. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.JAMA. 2002;288(3):321-333.

134. Women's Health Initiative. Available at . Last accessed January 26, 2023.

135. Bruckner MC, Youngkin EO. What's a woman to do? Exploring HRT questions raised by the women's health initiative.Nurs Womens Health. 2002;6(5):408-417.

136. Johansen LL, Thinggaard M, Hallas J, Osler M, Christensen K. Postmenopausal hormone therapy and mortality before and after the Women's Health Initiative Study.Sci Rep. 2023;13(1):539.

137. Nelson R. Hormone Therapy May Still Have Role in Osteoporosis Treatment. Available at Last accessed January 26, 2023.

138. Maxson J. Remedying dyslipidemia: NCEP-ATP III strategies to slow CVD.Clin Rev. 2002;12(10):53-60.

139. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study.N Engl J Med. 1991;325(11):756-762.

140. Main C, Knight B, Moxham T, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women.Cochrane Database Syst Rev. 2013;(4):CD002229.

141. 141. Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women.Cochrane Database Syst Rev. 2015;(3):CD002229.

142. Chester RC, Kling JM, Manson JE. What the Women's Health Initiative has taught us about menopausal hormone therapy.Clin Cardiol. 2018;41(2):247-252.

143. National Institute for Health and Care Excellence. Menopause: Diagnosis and Management: Recommendations. Available at Last accessed January 26, 2023.

144. Hale GE, Shufelt CL. Hormone therapy in menopause: an update on cardiovascular disease considerations.Trends Cardiovasc Med. 2015;25(6):540-549.

145. Harman SM. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.Fertil Steril. 2014;101(4):887-897.

146. Baber RJ, Panay N, Fenton A, and the IMS Writing Group. 2016 IMS recommendations on women's midlife health and menopause hormone therapy.Climacteric. 2016;19(2):109-150.

147. de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised Global Consensus Statement on Menopausal Hormone Therapy. Available at Last accessed January 26, 2023.

148. American Cancer Society. Menopausal Hormone Replacement Therapy and Cancer Risk. Available at Last accessed January 26, 2023.

149. Deli T, Orosz M, Jakab A. Hormone replacement therapy in cancer survivors – review of the literature.Pathol Oncol Res. 2020;26(1):63-78.

150. Richards SS, Hendrie HC. Diagnosis, management and treatment of Alzheimer's disease: a guide for the internist.Arch Intern Med. 1999;159(8):789-798.

151. Zhou CC, Wu Q, Wang Z, Wang Q, Liang Y, Liu S. The effect of hormone replacement therapy on cognitive function in female patients with Alzheimer's disease: a meta-analysis.Am J Alzheimers Dis Other Demen. 2020;35:1533317520938585.

152. 2022 Alzheimer's Disease Facts and Figures. Available at Last accessed January 26, 2023.

153. 153. Brinton RD. A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health.Int J Fertil Womens Med. 1999;44(4):174-185.

154. Manly JJ, Merchant CA, Jacobs DM, et al. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women.Neurology. 2000;54(4):833-837.

155. Hogervorst E, Yaffe K, Richards M, Huppert FA. Hormone replacement therapy to maintain cognitive function in women with dementia.Cochrane Database Syst Rev. 2009;21(1):CD003799.

156. Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women.Cochrane Database Syst Rev. 2008;23(1):CD003122.

157. U.S. Preventive Services Task Force. Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions. Available at Last accessed January 26, 2023.

158. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoporosis. Available at Last accessed January 26, 2023.

159. 159. Wactawski-Wende J. Periodontal diseases and osteoporosis: association and mechanisms.Ann Periodontol. 2001;6(1):197-208.

160. Dodd DZ, Rowe DJ. The relationship between postmenopausal osteoporosis and periodontal disease.J Dent Hyg. 2013;87(6):336-344.

161. Yu B, Wang CY. Osteoporosis and periodontal diseases – an update on their association and mechanistic links.Periodontol 2000. 2022;89(1):99-113.

162. Hong SJ, Yang BE, Yoo DM, Kim SJ, Choi HG, Byun SH. Analysis of the relationship between periodontitis and osteoporosis/fractures: a cross-sectional study.BMC Oral Health. 2021;21(1):125.

163. Alli F, Bhandal GK, Thacker HL, Palomo L. Can the FRAX tool be a useful aid for clinicians in referring women for periodontal care?Menopause. 2015;22(1):75-80.

164. 164. Grodstein F, Colditz GA, Stampfer MJ. Post-menopausal hormone use and tooth loss: a prospective study.J Am Dent Assoc. 1996;127(3):370-377.

165. Paganini-Hill A. The benefits of estrogen replacement therapy on oral health: the Leisure World Cohort.Arch Intern Med. 1995;155(21):2325-2329.

166. Jeffcoat MK, Reddy MS. Alveolar bone loss and osteoporosis: evidence for a common mode of therapy using the bisphosphonate alendronate. In: Davidovitch Z (ed).The Biologic Mechanism of Tooth Eruption, Resorption and Replacement by Implants. Boston, MA: Harvard Society for the Advancement of Orthodontics; 1998.

167. Helmi M, AlOsaimy S, Goodson JM, Hasturk H, Natto ZS. Annual alveolar bone loss in older adults taking oral bisphosphonate: a retrospective cohort study.BMC Oral Health. 2019;19:260.

168. Giannobile WV. Host-response therapeutics for periodontal diseases.J Periodontol. 2008;79(8 Suppl):1592-1600.

169. 169. Takaishi Y, Miki T, Nishizawa Y, Morii H. Clinical effect of etidronate on alveolar pyorrhoea associated with chronic marginal periodontitis: report of four cases.J Int Med Res. 2001;29:355-365.

170. Rocha M, Nava LE, Vázquez de la Torre C, Sánchez-Marin F, Garay-Sevilla ME, Malacara JM. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial.J Periodontol. 2001;72:204-209.

171. American Association of Oral and Maxillofacial Surgeons. Position Paper: Medication-Related Osteonecrosis of the Jaw—2022 Update. Available at Last accessed January 26, 2023.

172. Anil S, Preethanath RS, AlMoharib HS, Kamath KP, Anand PS. Impact of osteoporosis and its treatment on oral health.Am J Med Sci. 2013;346(5):396-401.

173. LeBoff MS. Greenspan SL, Insogna KL, et al. The clinician's guide to prevention and treatment of osteoporosis.Osteoporosis International. 2022;33:2049-2102.

174. Mauck KF, Clarke BL. Diagnosis, screening, prevention, and treatment of osteoporosis.Mayo Clin Proc. 2006;81(5):662-672.

175. North American Menopause Society. Management of osteoporosis in postmenopausal women: 2010 position statement of the North American Menopause Society.Menopause. 2010;17(1):25-54.

176. Gamble CL. Osteoporosis: drug and nondrug therapies for the patient at risk.Geriatrics. 1995;50(8):39-43.

177. LexiComp Online. Available at Last accessed January 26, 2023.

178. Daily Med. PROLIA-Denosumab Injection. Available at Last accessed January 26, 2023.

179. U.S. Food and Drug Administration. Denosumab: Highlight of Prescribing Information. Available at Last accessed January 26, 2023.

180. McClung M. Role of RANKL inhibition in osteoporosis.Arthritis Res Ther. 2007;9(Suppl 1):S3.

181. 181. U.S. Food and Drug Administration. FDA Approves New Treatment for Osteoporosis in Postmenopausal Women at High Risk of Fracture. Available at Last accessed January 26, 2023.

182. Moore A. Menopausal health strategies: focus on osteoporosis.Am J Nurse Pract. 2003;7(2):9-21.

183. Office on Women's Health. Osteoporosis. Available at Last accessed January 26, 2023.

184. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics: 2022update: a report from the American Heart Association.Circulation. 2022;145(8):e153-e639.

185. Centers for Disease Control and Prevention. Women and Heart Disease. Available at Last accessed January 26, 2023.

186. American Heart Association. Heart Attack Symptoms in Women. Available at Last accessed January 26, 2023.

187. American Heart Association. Menopause and Heart Disease. Available at Last accessed January 26, 2023.

188. Office on Women's Health. Stroke. Available at Last accessed January 26, 2023.

189. 189. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction.BMJ. 1989;298(6676):779-781.

190. Mattila KJ, Valle MS, Nieminen MS, et al. Dental infections and coronary atherosclerosis.Atherosclerosis. 1993;103(2):205-211.

191. Willershausen B, Kasaj A, Willershausen I, et al. Association between chronic dental infection and acute myocardial infarction.J Endod. 2009;35(5):626-630.

192. Kaisare S, Rao J, Dubashi N. Periodontal disease as a risk factor for acute myocardial infarction: a case-control study in Goans highlighting a review of the literature.Br Dent J. 2007;203(3):E5.

193. Stein JM, Kuch B, Conrads G, et al. Clinical periodontal and microbiologic parameters in patients with acute myocardial infarction.J Periodontol. 2009;80(10):1581-1589.

194. 194. Nalliah RP, Basu T, Chang CH. Association between periodontal care and hospitalization with acute myocardial infarction.J Am Dent Assoc. 2022;153(8):776-786.

195. Wilson K, Liu Z, Huang J, Roosaar A, Axéll T, Ye W. Poor oral health and risk of incident myocardial infarction: a prospective cohort study of Swedish adults, 1973-2012.Sci Rep. 2018;8(1):11479.

196. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality.BMJ. 1993;306(6879):688-691.

197. Rahimi A, Afshari Z. Periodontitis and cardiovascular disease: a literature review.ARYA Atheroscler. 2021;17(5):1-8.

198. Meregildo-Rodriguez ED, Robles-Arce LG, Chunga-Chévez EV, et al. Periodontal disease as a nontraditional risk factor for acute coronary syndrome: a systematic review and meta-analysis.Infez Med. 2022;30(4):501-515.

199. 199. Suzuki J, Aoyama N, Ogawa M, et al. Periodontitis and cardiovascular disease.Expert Opin Ther Targets. 2010;13(10):1023-1027.

200. Krejci CB, Bissada NF. Women's health issues and their relationship to periodontitis.J Am Dent Assoc. 2002;133(2):323-329.

201. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. Periodontol. 2000;71(10):1554-1560.

202. Issrani R, Reddy J, El-Metwally Dabah TH, Prabhu N, et al. Exploring the mechanisms and association between oral microflora and systemic diseases.Diagnostics (Basel). 2022;12(11):2800.

203. Centers for Disease Control and Prevention. Sexually Transmitted Diseases (STDs). Available at Last accessed January 26, 2023.

204. Rajendran R, Sivapathasundharam B (eds).Shafer's Textbook of Oral Pathology. 7th ed. New Delhi: Elsevier; 2012.

205. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021.MMWR Recomm Rep. 2021;70(4):1-187.

206. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2020: National Overview. Available at Last accessed January 26, 2023.

207. Bobak I, Lowdermilk D, Jensen M.Maternity and Gynecologic Care: The Nurse and the Family. 5th ed. St. Louis, MO: Mosby; 1997.

208. Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organizations' global strategy for prevention and assessment of HIV drug resistance.Antiviral Therapy. 2008;13(Suppl 2):1-13.

209. Lin JA, Woods ER, Bern EM. Common and emergent oral and gastrointestinal manifestations of eating disorders.Gastroenterol Hepatol ( N Y). 2021;17(4):157-167.

210. 210. van Eeden AE, van Hoeken D, Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and bulimia nervosa.Curr Opin Psychiatry. 2021;34(6):515-524.

211. Brown S, Bonifazi DZ. An overview of anorexia and bulimia nervosa and the impact of eating disorders on the oral cavity.Compendium. 1993;14(12):1594-1608.

212. DeBate RD, Tedesco LA, Kerschbaum WE. Knowledge of oral and physical manifestations of anorexia and bulimia nervosa among dentist and dental hygienists.J Dent Educ. 2005;69(3):346-354.

213. Chiba FY, Chiba EK, Moimaz AS, Matsushita DH, Garbin AJI, Garbin CAS. Malocclusion and its relationship with oral health-related quality of life in patients with eating disorders.Dental Press J Orthod. 2022;27(2):e2220305.

214. Lifante-Olivia C, Lopez-Jornet P. Camacho-Alonson F, Esteve-Salinas J. Study of oral changes in patients with eating disorders.Int J Dent Hyg. 2008;6(2):119-122.

215. 215. Mandel L, Kayna A. Bulimia and parotid swelling: a review and case report.J Oral Maxillofac Surg. 1992;50(10):1122-1125.

216. Ruff JC, Koch MO, Perkins S. Bulimia: dentomedical complications.Gen Dent. 1992;40(1):22-25.

217. Debate RD, Tedesco LA. Increasing dentists' capacity for secondary prevention of eating disorders: identification of training, network, and professional contingencies.J Dent Educ. 2006;70(10):1066-1075.

218. Lo Russo L, Campisi G, De Fede O, Di Liberto C, Panzarella V, Lo Muzio L. Oral manifestations of eating disorders: a critical review.Oral Dis. 2008;14(6):479-484.

219. Council on Scientific Affairs American Medical Association. Violence against women: relevance for medical practitioners.JAMA. 1992;267(33):3184-3189.

220. 220. Shipway L.Domestic Violence: A Handbook for Health Professionals. New York, NY: Routledge; 2004.

221. World Health Organization. Violence Against Women. Available at Last accessed January 26, 2023.

222. Scherer D. Tort remedies for victims of domestic abuse.South Carolina Law Rev. 1992;43:543-579.

223. National Institute of Justice. Overview of Intimate Partner Violence. Available at Last accessed January 26, 2023.

224. Centers for Disease Control and Prevention. Violence Prevention: Risk and Protective Factors for Perpetration. Available at Last accessed January 26, 2023.

225. Futures Without Violence. National Consensus Guidelines on Identifying and Responding to Domestic Violence Victimization in Health Care Settings. Available at Last accessed January 26, 2023.

226. McLeer SV, Anwar RA. The role of the emergency physician in the prevention of domestic violence.Ann Emerg Med. 1987;16(10):1155-1161.

227. Chez RA, Jones RF. The battered woman.Am J Obstet Gynecol. 1995;173(3):677-679.

Copyright © 2023 NetCE, PO Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.